Insider Transactions in Q1 2021 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 04
2021
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
970
+2.93%
|
-
|
Feb 04
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-2.26%
|
$41,701
$223.78 P/Share
|
Feb 04
2021
|
Paul R Kirchgraber CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
560
+6.35%
|
-
|
Feb 04
2021
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-3.42%
|
$34,342
$223.78 P/Share
|
Feb 04
2021
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
560
+11.05%
|
-
|
Feb 04
2021
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-35.34%
|
$20,962
$223.78 P/Share
|
Feb 04
2021
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
266
+50.0%
|
-
|
Feb 04
2021
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.88%
|
$18,509
$223.78 P/Share
|
Feb 04
2021
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+6.37%
|
-
|
Feb 04
2021
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
53
-9.2%
|
$11,819
$223.78 P/Share
|
Feb 04
2021
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150
+20.66%
|
-
|
Feb 04
2021
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-8.35%
|
$229,244
$223.78 P/Share
|
Feb 04
2021
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,506
+22.16%
|
-
|
Jan 26
2021
|
R Sanders Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+19.86%
|
$127,400
$98.49 P/Share
|